Generic placeholder image

Current Medicinal Chemistry


ISSN (Print): 0929-8673
ISSN (Online): 1875-533X


Short Commentary on “Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis, and Therapy”

Author(s): Yusuf Tutar*

Volume 27 , Issue 42 , 2020

Page: [7289 - 7292] Pages: 4

DOI: 10.2174/092986732742201105113054

Price: $65

Tutar, Y.; Özgür, A.; Tutar, E.; Tutar, L.; Pulliero, A.; Izzotti, A. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer. Biomed. Pharmacother., 2016, 83, 1182-1190.
[] [PMID: 27551766]
Ozgur, A.; Tutar, L.; Tutar, Y. Regulation of heat shock proteins by miRNAs in human breast cancer. MicroRNA, 2014, 3(2), 118-135.
[] [PMID: 25541910]
Mercer, T.R.; Dinger, M.E.; Mattick, J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet., 2009, 10(3), 155-159.
[] [PMID: 19188922]
Shi, J.; Dong, B.; Cao, J.; Mao, Y.; Guan, W.; Peng, Y.; Wang, S. Long non-coding RNA in glioma: signaling pathways. Oncotarget, 2017, 8(16), 27582-27592.
[] [PMID: 28187439]
Pandey, G.K.; Kanduri, C. Long noncoding RNAs and neuroblastoma. Oncotarget, 2015, 6(21), 18265-18275.
[] [PMID: 26087192]
Young, R.M.; Jamshidi, A.; Davis, G.; Sherman, J.H. Current trends in the surgical management and treatment of adult glioblastoma. Ann. Transl. Med., 2015, 3(9), 121.
[] [PMID: 26207249]
Khosla, D. Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Ann. Transl. Med., 2016, 4(3), 54.
[] [PMID: 26904576]
Maris, J.M.; Hogarty, M.D.; Bagatell, R.; Cohn, S.L. Neuroblastoma. Lancet, 2007, 369(9579), 2106-2120.
[] [PMID: 17586306]
Bian, E.B.; Li, J.; Xie, Y.S.; Zong, G.; Li, J.; Zhao, B. LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2. J. Cell. Physiol., 2015, 230(3), 496-503.
[] [PMID: 24403021]
Zhang, X.; Sun, S.; Pu, J.K.; Tsang, A.C.; Lee, D.; Man, V.O.; Lui, W.M.; Wong, S.T.; Leung, G.K. Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol. Dis., 2012, 48(1), 1-8.
[] [PMID: 22709987]
Grzmil, M.; Morin, P., Jr; Lino, M.M.; Merlo, A.; Frank, S.; Wang, Y.; Moncayo, G.; Hemmings, B.A. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma. Cancer Res., 2011, 71(6), 2392-2402.
[] [PMID: 21406405]
Baritaki, S.; Chatzinikola, A.M.; Vakis, A.F.; Soulitzis, N.; Karabetsos, D.A.; Neonakis, I.; Bonavida, B.; Spandidos, D.A. YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels. Cancer Invest., 2009, 27(2), 184-192.
[] [PMID: 19235591]
Guo, H.; Wu, L.; Yang, Q.; Ye, M.; Zhu, X. Functional linc-POU3F3 is overexpressed and contributes to tumorigenesis in glioma. Gene, 2015, 554(1), 114-119.
[] [PMID: 25445282]
Shi, Y.; Wang, Y.; Luan, W.; Wang, P.; Tao, T.; Zhang, J.; Qian, J.; Liu, N.; You, Y. Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675. PLoS One, 2014, 9(1)e86295
[] [PMID: 24466011]
Ma, K.X.; Wang, H.J.; Li, X.R.; Li, T.; Su, G.; Yang, P.; Wu, J.W. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol., 2015, 36(5), 3355-3359.
[] [PMID: 25613066]
Vital, A.L.; Tabernero, M.D.; Castrillo, A.; Rebelo, O.; Tão, H.; Gomes, F.; Nieto, A.B.; Resende Oliveira, C.; Lopes, M.C.; Orfao, A. Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology. Neuro-oncol., 2010, 12(9), 991-1003.
[] [PMID: 20484145]
Pandey, G.K.; Kanduri, C. Fighting neuroblastomas with NBAT1. Oncoscience, 2015, 2(2), 79-80.
[] [PMID: 25859549]
Zhang, X.Q.; Sun, S.; Lam, K.F.; Kiang, K.M.; Pu, J.K.; Ho, A.S.; Lui, W.M.; Fung, C.F.; Wong, T.S.; Leung, G.K. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol. Dis., 2013, 58, 123-131.
[] [PMID: 23726844]
Chen, H.; Li, X.; Li, W.; Zheng, H. miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, inde-pendently of O6-methylguanine-DNAmethyltransferase. J. Transl. Med., 2015, 13, 69.
[] [PMID: 25890369]
Barsyte-Lovejoy, D.; Lau, S.K.; Boutros, P.C.; Khosravi, F.; Jurisica, I.; Andrulis, I.L.; Tsao, M.S.; Penn, L.Z. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res., 2006, 66(10), 5330-5337.
[] [PMID: 16707459]
Wang, Y.; Wang, Y.; Li, J.; Zhang, Y.; Yin, H.; Han, B. CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling. Cancer Lett., 2015, 367(2), 122-128.
[] [PMID: 25813405]
Han, Y.; Wu, Z.; Wu, T.; Huang, Y.; Cheng, Z.; Li, X.; Sun, T.; Xie, X.; Zhou, Y.; Du, Z. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling. Cell Death Dis., 2016, 7e2123
[] [PMID: 26938295]
Brodeur, G.M.; Seeger, R.C.; Schwab, M.; Varmus, H.E.; Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 1984, 224(4653), 1121-1124.
[] [PMID: 6719137]
Seeger, R.C.; Brodeur, G.M.; Sather, H.; Dalton, A.; Siegel, S.E.; Wong, K.Y.; Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 1985, 313(18), 1111-1116.
[] [PMID: 4047115]
Liu, P.Y.; Erriquez, D.; Marshall, G.M.; Tee, A.E.; Polly, P.; Wong, M.; Liu, B.; Bell, J.L.; Zhang, X.D.; Milazzo, G.; Cheung, B.B.; Fox, A.; Swarbrick, A.; Hüttelmaier, S.; Kavallaris, M.; Perini, G.; Mattick, J.S.; Dinger, M.E.; Liu, T. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J. Natl. Cancer Inst., 2014, 106(7)dju113
[] [PMID: 24906397]
Zhou, X.; Ren, Y.; Zhang, J.; Zhang, C.; Zhang, K.; Han, L.; Kong, L.; Wei, J.; Chen, L.; Yang, J.; Wang, Q.; Zhang, J.; Yang, Y.; Jiang, T.; Li, M.; Kang, C. HOTAIR is a therapeutic target in glioblastoma. Oncotarget, 2015, 6(10), 8353-8365.
[] [PMID: 25823657]
Chen, W.; Xu, X.K.; Li, J.L.; Kong, K.K.; Li, H.; Chen, C.; He, J.; Wang, F.; Li, P.; Ge, X.S.; Li, F.C. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Oncotarget, 2017, 8(14), 22783-22799.
[] [PMID: 28187000]
Kim, S.S.; Harford, J.B.; Moghe, M.; Rait, A.; Pirollo, K.F.; Chang, E.H. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic Acids Res., 2018, 46(3), 1424-1440.
[ ] [PMID: 29202181]
Du, P.; Zhao, H.; Peng, R.; Liu, Q.; Yuan, J.; Peng, G.; Liao, Y. LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. Biosci. Rep., 2017, 37(5)BSR20170696
[] [PMID: 28831025]
Brodie, S.; Lee, H.K.; Jiang, W.; Cazacu, S.; Xiang, C.; Poisson, L.M.; Datta, I.; Kalkanis, S.; Ginsberg, D.; Brodie, C. The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells. Oncotarget, 2017, 8(19), 31785-31801.
[] [PMID: 28423669]
Yue, B.; Cai, D.; Liu, C.; Fang, C.; Yan, D. Linc00152 functions as a competing endogenous RNA to confer oxaliplatin resistance and holds prognostic values in colon cancer. Mol. Ther., 2016, 24(12), 2064-2077.
[] [PMID: 27633443]
Shen, S.; Sun, Q.; Liang, Z.; Cui, X.; Ren, X.; Chen, H.; Zhang, X.; Zhou, Y. A prognostic model of triple-negative breast cancer based on miR-27b-3p and node status. PLoS One, 2014, 9(6)e100664
[] [PMID: 24945253]
Zou, H.; Wu, L.X.; Yang, Y.; Li, S.; Mei, Y.; Liu, Y.B.; Zhang, L.; Cheng, Y.; Zhou, H.H. lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients. Oncotarget, 2017, 8(45), 78767-78780.
[] [PMID: 29108264]
Gupta, R.A.; Shah, N.; Wang, K.C.; Kim, J.; Horlings, H.M.; Wong, D.J.; Tsai, M.C.; Hung, T.; Argani, P.; Rinn, J.L.; Wang, Y.; Brzoska, P.; Kong, B.; Li, R.; West, R.B.; van de Vijver, M.J.; Sukumar, S.; Chang, H.Y. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 2010, 464(7291), 1071-1076.
[] [PMID: 20393566]
Wang, Q.; Zhang, J.; Liu, Y.; Zhang, W.; Zhou, J.; Duan, R.; Pu, P.; Kang, C.; Han, L. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett., 2016, 373(2), 251-259.
[] [PMID: 26828136]
Lv, Q.L.; Hu, L.; Chen, S.H.; Sun, B.; Fu, M.L.; Qin, C.Z.; Qu, Q.; Wang, G.H.; He, C.J.; Zhou, H.H. A Long noncoding RNA ZEB1-AS1 promotes tumorigenesis and predicts poor prognosis in glioma. Int. J. Mol. Sci., 2016, 17(9)E1431
[] [PMID: 27589728]
Hu, G.W.; Wu, L.; Kuang, W.; Chen, Y.; Zhu, X.G.; Guo, H.; Lang, H.L. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway. Gene, 2017, 610, 24-31.
[] [PMID: 28189759]
Hu, L.; Lv, Q.L.; Chen, S.H.; Sun, B.; Qu, Q.; Cheng, L.; Guo, Y.; Zhou, H.H.; Fan, L. Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma. Int. J. Environ. Res. Public Health, 2016, 13(4), 433.
[] [PMID: 27104549]
Liao, Y.; Shen, L.; Zhao, H.; Liu, Q.; Fu, J.; Guo, Y.; Peng, R.; Cheng, L. LncRNA CASC2 interacts with miR-181a to modulate glioma growth and resistance to TMZ through PTEN pathway. J. Cell. Biochem., 2017, 118(7), 1889-1899.
[] [PMID: 28121023]

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy